Viatris Sways Judge To Ax AstraZeneca Inhaler Patent
A West Virginia federal judge has granted drugmaker Viatris' bid to invalidate one of rival AstraZeneca's patents on brand name asthma treatment Symbicort, determining that the challenged claims are invalid for...To view the full article, register now.
Already a subscriber? Click here to view full article